ScholarIQanswers from OpenAlex

Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results.

PaperCitations, authors & open-access status

Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. have?

ScholarIQcitation count

Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. has 136 citations in the OpenAlex counts ScholarIQ stores.

When was Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. published?

ScholarIQyear

Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. has 2003 year in the ScholarIQ index.

What is the open-access status of Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results.?

ScholarIQoa status

Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. has closed oa status in the ScholarIQ index.

What is the PMID of Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results.?

ScholarIQpmid

The PMID for Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. is on the source record.

What is the OpenAlex record for Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results.?

ScholarIQopenalex

The OpenAlex for Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial